Skip to main content
    H

    Humacyte Inc (HUMA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.50
    -0.04 (-7.27%)

    Market Cap: $155.12M

    Last updated: Nov 17, 2026 at 4:28 PM ET

    Humacyte Inc (HUMA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Humacyte (HUMA) has a latest price of $0.50 on Nov 17, 2026, 67.1% below its 52-week high of $1.52. Its price fell 59.3% over the past 12 months. The month-end price fell 95.5% over the 5 years through Oct 2026, a compound annual decline of 46.2%.

    Price Chart

    From Aug 2021 to Oct 2026, its highest month-end close was $14.62 in Aug 2021 and its lowest $0.41 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart HUMA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for HUMA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 31.8%, and over 6 months it fell 39.3%. The month-end price fell 80.6% over the 3 years through Oct 2026, a compound annual decline of 42.1%.

    PeriodChange
    1 month+24.9%
    3 months-31.8%
    6 months-39.3%
    12 months-59.3%
    12 months, with dividends-59.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-80.6%-42.1%
    5 years-95.5%-46.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 77.8%, and its weakest was 2025, when it fell 81.0%.

    YearCloseChange
    2026 through Oct 2026$0.41-57.2%
    2025$0.96-81.0%
    2024$5.05+77.8%
    2023$2.84+34.6%
    2022$2.11-70.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 2.1% above its 50-day average of $0.49 and 35.3% below its 200-day average of $0.77.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.50
    52-week high$1.52-67.1%
    52-week low$0.34+48.7%
    50-day average$0.49+2.1%
    200-day average$0.77-35.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 96.3%.

    MeasureValue
    1-year beta2.67
    Largest fall, 1 year-76.2%
    Largest fall, 3 years-96.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About HUMA

    What is HUMA's 1-year price change?

    Humacyte's price fell 59.3% over the past 12 months. With dividends included, the 12-month total return was -59.3%.

    What is HUMA's 5-year price change?

    Humacyte's month-end price fell 95.5% over the 5 years through Oct 2026, a compound annual decline of 46.2%. These figures leave out dividends.

    What is HUMA's 52-week high and low?

    Humacyte's 52-week high is $1.52 and its 52-week low is $0.34. Its latest price of $0.50 on Nov 17, 2026 is 67.1% below the high.

    What is HUMA's beta?

    Humacyte's 1-year beta against the S&P 500 is 2.67, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 76.2%.

    Is the HUMA chart free?

    Yes. Advanced Charting for HUMA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.